May 07, 2019
Voyager Therapeutics
Voyager Therapeutics Reports First Quarter 2019 Financial Results and Corporate Highlights.
May 06, 2019
Magenta Therapeutics
Magenta Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares.
May 06, 2019
Sage Therapeutics
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4).
May 05, 2019
Voyager Therapeutics
Neurocrine Biosciences and Voyager Therapeutics Announce Phase I Results for VY-AADC in Patients with Parkinson’s Disease at the American Academy of Neurology Annual Meeting.